# Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation

> **NCT01581515** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Promus Element everolimus eluting coronary stent
- **DEVICE:** Xience Prime everolimus eluting coronary stent

## Key facts

- **NCT ID:** NCT01581515
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581515, "Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01581515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
